Literature DB >> 8725560

Angiotensin converting enzyme inhibitors--do they have an anti-ischemic action?

J D Rutherford1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8725560      PMCID： PMC2376555     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN： 0065-7778


× No keyword cloud information.
  41 in total

1.  In vitro stimulation of plasminogen activator release from vein walls by adrenaline.

Authors:  A Kjaeldgaard; M Kjaeldgaard
Journal:  J Clin Pathol       Date:  1986-11       Impact factor: 3.411

2.  Effects of captopril on the physical work capacity of normotensive patients with stable-effort angina pectoris.

Authors:  C Strozzi; G Cocco; F Portaluppi; L Urso; R Alfiero; M T Tasini; L Montanari; K Al Yassini; A Rizzo
Journal:  Cardiology       Date:  1987       Impact factor: 1.869

3.  Fibrinogen and risk of cardiovascular disease. The Framingham Study.

Authors:  W B Kannel; P A Wolf; W P Castelli; R B D'Agostino
Journal:  JAMA       Date:  1987-09-04       Impact factor: 56.272

4.  Comparison of enalapril versus captopril on left ventricular function and survival three months after acute myocardial infarction (the "PRACTICAL" study).

Authors:  S G Foy; I G Crozier; J G Turner; A M Richards; C M Frampton; M G Nicholls; H Ikram
Journal:  Am J Cardiol       Date:  1994-06-15       Impact factor: 2.778

5.  Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

Authors:  A Hamsten; U de Faire; G Walldius; G Dahlén; A Szamosi; C Landou; M Blombäck; B Wiman
Journal:  Lancet       Date:  1987-07-04       Impact factor: 79.321

6.  Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators.

Authors:  J D Rutherford; M A Pfeffer; L A Moyé; B R Davis; G C Flaker; P R Kowey; G A Lamas; H S Miller; M Packer; J L Rouleau
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

7.  Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

Authors:  S G Thompson; J Kienast; S D Pyke; F Haverkate; J C van de Loo
Journal:  N Engl J Med       Date:  1995-03-09       Impact factor: 91.245

8.  Ergometric evaluation of the effects of enalapril maleate in normotensive patients with stable angina.

Authors:  C Strozzi; F Portaluppi; G Cocco; L Urso
Journal:  Clin Cardiol       Date:  1988-04       Impact factor: 2.882

9.  Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction.

Authors:  R A Wright; A D Flapan; K G Alberti; C A Ludlam; K A Fox
Journal:  J Am Coll Cardiol       Date:  1994-07       Impact factor: 24.094

Review 10.  The role of endothelium in cardiovascular homeostasis and diseases.

Authors:  G M Rubanyi
Journal:  J Cardiovasc Pharmacol       Date:  1993       Impact factor: 3.105
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.